About Us

 

Our history

Customer Orientation

The continuous development of our management structure has led to the creation of product management and technical service functions within marketing and sales management.
We enhance the promotion of better customer relationships and market information. Training activities for our facilities personnel continue, with special emphasis on the development of managerial capabilities.

We are expanding our activities in the development of new processes and products in the booming biotechnological area.
Also, we are open to cooperation through a responsible partnership approach, based on the quality and reliability of our products and services.
Our aim is to further strengthen our relations with customers to ensure a long term sustained profitability.

We retain an important share in the global market thanks to strict quality control, investment in R&D know-how expertise, human resources as well as vertical and international integration.
We are a strong key partner of the multinational pharmaceutical companies for the production of Active Pharmaceutical Ingredients.

We sell our products in more than 50 countries worldwide.
All our plants operate in compliance with GMP and we are ISO 9001 certified.

We offer Contract manufacturing services to multinational corporations, large pharmaceutical organizations and other companies who would like to outsource products for toll manufacturing.


Milestones of our history

Year
Milestone
   
1947
Letter from Sir Alexander Fleming to the pioneers of Antibióticos, S.A.
1954
Antibióticos S.A. was established in Spain. Begins penicillin G production.
1965
Begins manufacture of 6-APA chemical pathway.
1969
Starts manufacture of ampicillin, amoxicillin and sterile beta- lactams.
1975
Begins manufacture of 7-ADCA chemical pathway and cephalexin.
1981
Begins manufacture of enzymatic 6-APA.
1987
Acquisition of Antibioticos S.A. and reorganization of Montedison’s pharmaceutical Bulk commodities activities in the newly established Antibióticos Group.
1992
Installation of new Wastewater Treatment Plant.
1998
Start up of the enzymatic process for 7-ADCA.
2003
Acquisition of Antibioticos group by Fidia Farmaceutici.
2006
Start-up custom manufacturing for beta-lactams and sterile beta- lactams.
2009
Acquisition of Antibioticos S.A. by a spanish group.